fusidic acid has been researched along with tacrolimus in 9 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | fusidic acid (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Kirisits, W; Kotanko, P; Skrabal, F | 1 |
| Chiang, BL; Chu, CY; Hung, SH; Lee, CC; Liang, TC; Lin, YT; Wang, LC; Yang, YH | 1 |
| Bovenschen, HJ; Groeneveld-Haenen, CP | 1 |
| An, Q; Chen, HD; Gao, XH; Hong, YX; Qi, RQ; Song, B; Sun, M; Zhai, JL; Zhang, L | 1 |
| Baraldi, C; Barruscotti, S; Chessa, MA; Gurioli, C; Leuzzi, M; Neri, I; Savoia, F; Sechi, A; Virdi, A | 1 |
| Baek, SY; Kim, HI; Kim, JH; Kim, YK; Shin, DW; Woo, IS | 1 |
1 review(s) available for fusidic acid and tacrolimus
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
1 trial(s) available for fusidic acid and tacrolimus
| Article | Year |
|---|---|
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics.
Topics: Adolescent; Adult; Androstadienes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Dermatitis, Atopic; Drug Therapy, Combination; Female; Fluticasone; Fusidic Acid; Humans; Immunosuppressive Agents; Infant; Male; Staphylococcal Skin Infections; Staphylococcus; Tacrolimus | 2007 |
7 other study(ies) available for fusidic acid and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Rhabdomyolysis and acute renal graft impairment in a patient treated with simvastatin, tacrolimus, and fusidic acid.
Topics: Acute Disease; Anti-Bacterial Agents; Drug Interactions; Female; Fusidic Acid; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Rhabdomyolysis; Simvastatin; Tacrolimus; Treatment Failure | 2002 |
Topical tacrolimus induced extensive varicella zoster infection.
Topics: Acyclovir; Antiviral Agents; Dermatitis, Atopic; Dermatologic Agents; Drug Therapy, Combination; Female; Fusidic Acid; Herpes Zoster; Herpesvirus 3, Human; Humans; Middle Aged; Ointments; Tacrolimus; Treatment Outcome; Valacyclovir; Valine | 2011 |
High
Topics: Dermatitis, Atopic; Dermatitis, Seborrheic; Fusidic Acid; HIV; Humans; Skin; Staphylococcus epidermidis; Tacrolimus | 2017 |
Zoon's plasma cell balanitis: clinical and dermoscopic features in pediatric patients.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Balanitis; Betamethasone; Biopsy; Dermoscopy; Fusidic Acid; Glucocorticoids; Humans; Infant; Male; Plasma Cells; Tacrolimus | 2018 |
Development and validation of a simultaneous analytical method for non-steroidal therapeutic compounds in cosmetics using liquid chromatography-tandem mass spectrometry.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bufexamac; Chlorpheniramine; Chromatography, High Pressure Liquid; Clotrimazole; Cosmetics; Doxepin; Fusidic Acid; Ketotifen; ortho-Aminobenzoates; Phthalazines; Tacrolimus; Tandem Mass Spectrometry | 2021 |